Read + Share
Amedeo Smart
Independent Medical Education
Lim SH, Gros B, Sharma E, Lehmann A, et al. Safety, Effectiveness, and Treatment Persistence of Subcutaneous Vedolizumab in IBD: A Multicenter Study From the United Kingdom. Inflamm Bowel Dis 2024;30:1284-1294.PMID: 37603730
Email
LinkedIn
Privacy Policy